Carl Batt

Carl Batt has been in the pharmaceutical business for over 15 years, working at Allergan for 12 of those years before joining Teva Pharmaceuticals. He then worked as CEO of Catalyst Helath. Carl was appointed CFO of Nkunzi Pharmaceuticals in 2022. He served as both Head of Finance and Group Financial Manager for Allergan. Prior to that, he was the Divisional Financial Director of Stantronic Group Holdings. He started his career as an Assistant Accountant at Standard Bank Group and, after a year, became an Accountant at Arthur Andersen & Co. He has both a B.Com and B.Compt degree in Accounting from UJ and UNISA respectively. He was appointed CFO of Teva in July 2016.

Work
2022 - Present     Chief Financial Officer, Nkunzi Pharmaceuticals
2020 - 2022         CEO, Catalyst Health
2016 – 2020        Chief Financial Officer, South Africa and Sub-Sahara Africa,Teva Pharmaceuticals 
2016 – 2016         Head of Finance, Generics, Allergan
2004 – 2016         Group Financial Manager, Allergan
1994 – 2002         Divisional Financial Director, Stantronic Group Holdings Ltd
1992 – 1994         Accounting, Auditing, Arthur Andersen & Co. 
1991 – 1992         Assistant Accountant, Standard Bank Group 

Education
2015                       Commissioner of Oaths
2015                       South African Institute of Tax Professionals
2010 – 2014         B.Compt, Accounting, UNISA
1989 – 1991         B.Com, Accounting, UJ
1981 – 1985         Matric, DF Malan High School


 About Nkunzi Pharmaceuticals: Nkunzi is a manufacturer and wholesaler of pharmaceuticals in Wadeville Gauteng.

Company: Nkunzi Pharmaceuticals

Job title: CFO

External profile: Click here

No items found.